Rexnord (RXN) Tops Q4 EPS by 5c

Rexnord (NYSE: RXN) reported Q4 EPS of $0.55, $0.05 better than the analyst estimate of $0.50. Revenue for the quarter came in at $547 million versus the consensus estimate of $538.13 million.

June Quarter Outlook:

Adams continued, “Due to the near to medium term uncertainty created by the COVID-19 pandemic, we will not be providing outlook for the entirety of the next nine months at this time. Based on the cost reduction actions we’ve taken, our backlog heading into the quarter, as well as taking into account recent and anticipated order patterns through June, we expect our sales to decline by between 18% and 23% in the June quarter, our total segment Adjusted EBITDA margin to range between 21% and 23%, and our corporate expenses to approximate $7 million."

For earnings history and earnings-related data on Rexnord (RXN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c